Pfizer enlists children and adults for Lyme disease vaccine in a late stage clinical trial
August 09, 2022 at 11:01 AM EDT
On Monday, Pfizer and Valneva announced they will enlist 6,000 participants for a late-stage clinical trial of a Lyme disease vaccine.